[1]
DE CARVALHO, D.S. et al. 2024. Simulation of the economic impact of introducing rivaroxaban in a high-complexity hospital for venous thromboembolism prophylaxis. Journal of Hospital Pharmacy and Health Services. 15, 3 (Jul. 2024), e1153. DOI:https://doi.org/10.30968/rbfhss.2024.153.1153.